Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xabier Garcia-Albeniz

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|September 25, 2023
Use of clinical classifications software to address ICD coding transition in large healthcare databases analyzed via high-dimensional propensity scoresLai San Hong, Xabier Garcia-Albeniz, David Friesen, et al.
Plos Medicine|July 21, 2025
Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trialsVanessa Voelskow, Xabier Garcia-Albeniz, Anita Berglund, et al.
International Journal of Cardiology|December 6, 2008
Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinibAna Garcia-Alvarez, Marta Sitges, Xabier Garcia-Albeniz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2015
The Role of Stage at Diagnosis in Colorectal Cancer Black-White Survival Disparities: A Counterfactual Causal Inference ApproachLinda Valeri, Jarvis T Chen, Xabier Garcia-Albeniz, et al.
European Heart Journal. Cardiovascular Imaging|January 25, 2014
Reporting standards in cardiac MRI, CT, and SPECT diagnostic accuracy studies: analysis of the impact of STARD criteriaEdd N Maclean, Ian S Stone, Felix Ceelen, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2026
Effectiveness of Indapamide Prolonged-Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial EmulationCéline Darricarrere, Virginie Simon, Manel Pladevall-Vila, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 25, 2010
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximabXabier Garcia-Albeniz, Carles Pericay, Virginia Alonso-Espinaco, et al.
Journal of the National Cancer Institute|February 26, 2014
A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancerRaaj S Mehta, Mingyang Song, Navya Bezawada, et al.
Medical Oncology (Northwood, London, England)|January 23, 2013
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancerJordi Codony-Servat, Xabier Garcia-Albeniz, Carles Pericay, et al.
Clinical Genitourinary Cancer|September 30, 2022
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in SwedenPär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|September 25, 2023
Use of clinical classifications software to address ICD coding transition in large healthcare databases analyzed via high-dimensional propensity scoresLai San Hong, Xabier Garcia-Albeniz, David Friesen, et al.
Plos Medicine|July 21, 2025
Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trialsVanessa Voelskow, Xabier Garcia-Albeniz, Anita Berglund, et al.
International Journal of Cardiology|December 6, 2008
Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinibAna Garcia-Alvarez, Marta Sitges, Xabier Garcia-Albeniz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2015
The Role of Stage at Diagnosis in Colorectal Cancer Black-White Survival Disparities: A Counterfactual Causal Inference ApproachLinda Valeri, Jarvis T Chen, Xabier Garcia-Albeniz, et al.
European Heart Journal. Cardiovascular Imaging|January 25, 2014
Reporting standards in cardiac MRI, CT, and SPECT diagnostic accuracy studies: analysis of the impact of STARD criteriaEdd N Maclean, Ian S Stone, Felix Ceelen, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2026
Effectiveness of Indapamide Prolonged-Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial EmulationCéline Darricarrere, Virginie Simon, Manel Pladevall-Vila, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 25, 2010
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximabXabier Garcia-Albeniz, Carles Pericay, Virginia Alonso-Espinaco, et al.
Journal of the National Cancer Institute|February 26, 2014
A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancerRaaj S Mehta, Mingyang Song, Navya Bezawada, et al.
Medical Oncology (Northwood, London, England)|January 23, 2013
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancerJordi Codony-Servat, Xabier Garcia-Albeniz, Carles Pericay, et al.
Clinical Genitourinary Cancer|September 30, 2022
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in SwedenPär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, et al.
Pageof 3